Bond IBRD-Global 1.3% ( US459058JR58 ) in USD

Issuer IBRD-Global
Market price refresh price now   84.85 %  ▲ 
Country  United States
ISIN code  US459058JR58 ( in USD )
Interest rate 1.3% per year ( payment 2 times a year)
Maturity 09/02/2031



Prospectus brochure of the bond IBRD US459058JR58 en USD 1.3%, maturity 09/02/2031


Minimal amount /
Total amount /
Cusip 459058JR5
Next Coupon 10/08/2025 ( In 39 days )
Detailed description The International Bank for Reconstruction and Development (IBRD) is an international financial institution that offers loans and advice to middle-income and creditworthy low-income countries for development projects.

The IBRD US459058JR58 bond, a USD-denominated instrument issued in the United States, currently trades at 84.52% of par value, offering a 1.3% coupon with semi-annual payments and maturing on September 2nd, 2031.







EXECUTION VERSION

Final Terms dated February 5, 2021
International Bank for Reconstruction and Development
Issue of US$3,500,000,000 1.250 per cent. Notes due February 10, 2031
under the
Global Debt Issuance Facility
Terms used herein shall be deemed to be defined as such for the purposes of the terms
and conditions (the "Conditions") set forth in the Prospectus dated May 28, 2008. This
document constitutes the Final Terms of the Notes described herein and must be read in
conjunction with such Prospectus.
UK MiFIR product governance / Retail investors, professional investors and ECPs target markets ­
See Term 28 below.
SUMMARY OF THE NOTES
1. Issuer:
International Bank for Reconstruction and Development
("IBRD")
2. (i) Series Number:
101302
(ii) Tranche Number:
1
3. Specified Currency or Currencies
United States Dollars ("US$")
(Condition 1(d)):
4. Aggregate Nominal Amount:

(i) Series:
US$3,500,000,000
(ii) Tranche:
US$3,500,000,000
5. (i) Issue Price:
99.738 per cent. of the Aggregate Nominal Amount
(ii) Net proceeds:
US$3,484,705,000
6. Specified Denominations
US$1,000 and integral multiples thereof
(Condition 1(b)):
7. Issue Date:
February 10, 2021
8. Maturity Date (Condition 6(a)):
February 10, 2031
9. Interest Basis (Condition 5):
1.250 per cent. Fixed Rate
(further particulars specified below)
10. Redemption/Payment Basis
Redemption at par
(Condition 6):
11. Change of Interest or
Not Applicable
Redemption/Payment Basis:
12. Call/Put Options (Condition 6):
Not Applicable
13. Status of the Notes (Condition 3):
Unsecured and unsubordinated
14. Listing:
Luxembourg Stock Exchange

4850-0617-1098 v.2



15. Method of distribution:
Syndicated
PROVISIONS RELATING TO INTEREST (IF ANY) PAYABLE
16. Fixed Rate Note Provisions
Applicable
(Condition 5(a)):
(i)
Rate of Interest:
1.250 per cent. per annum payable semi-annually in arrear
(ii) Interest Payment Date(s):
February 10 and August 10 of each year, from and including
August 10, 2021, to and including the Maturity Date, not
subject to adjustment in accordance with a Business Day
Convention
(iii) Interest Period Date(s):
Each Interest Payment Date
(iv) Business Day Convention:
Not Applicable
(v) Day Count Fraction
30/360
(Condition 5(l)):
(vi) Other terms relating to the
Not Applicable
method of calculating interest
for Fixed Rate Notes:
PROVISIONS RELATING TO REDEMPTION
17. Final Redemption Amount of each US$1,000 per minimum Specified Denomination
Note (Condition 6):
18. Early Redemption Amount
As set out in the Conditions
(Condition 6(c)):
GENERAL PROVISIONS APPLICABLE TO THE NOTES
19. Form of Notes (Condition 1(a)):
Fed Bookentry Notes:

Fed Bookentry Notes available on Issue Date
20. New Global Note:
No
21. Financial Centre(s) or other special New York
provisions relating to payment
dates (Condition 7(h)):
22. Governing law (Condition 14):
New York
23. Other final terms:
Not Applicable

DISTRIBUTION
24. (i) If syndicated, names of
Citigroup Global Markets Limited:
US$823,750,000
Managers and
J.P. Morgan Securities plc:
US$823,750,000
underwriting
Merrill Lynch International:
US$823,750,000
commitments:
RBC Capital Markets, LLC:
US$823,750,000


Barclays Bank PLC:
US$73,000,000
Crédit Agricole

Corporate and Investment Bank:
US$52,000,000
Deutsche Bank AG, London Branch:
US$2,000,000
National Bank of Canada Financial


-2-

4850-0617-1098 v.2



Inc.:
US$35,000,000
Wells Fargo Securities, LLC:
US$25,000,000


BMO Capital Markets Corp.:
US$2,000,000
CastleOak Securities, L.P.:
US$2,000,000
Daiwa Capital Markets Europe

Limited:
US$2,000,000
Goldman Sachs International:
US$2,000,000
HSBC Bank plc:
US$2,000,000
Jefferies LLC:
US$2,000,000
Morgan Stanley & Co. International

plc:
US$2,000,000
Nomura International plc:
US$2,000,000
The Toronto-Dominion Bank:
US$2,000,000



(ii) Stabilizing Manager(s)
RBC Capital Markets, LLC
(if any):
25. If non-syndicated, name of
Not Applicable
Dealer:
26. Total commission and
0.175 per cent. of the Aggregate Nominal Amount
concession:
27. Additional selling restrictions:
Not Applicable
28. UK MiFIR product
Regulation (EU) No 600/2014 as it forms part of domestic
governance
law by virtue of the European Union (Withdrawal) Act 2018
Retail investors, professional
("UK MiFIR") product governance / Retail investors,
investors and ECPs target
professional investors and eligible counterparties ("ECPs")
markets:
target market:

Solely for the purposes of the manufacturers' product approval
process, the target market assessment in respect of the Notes has
led to the conclusion that (i) the target market for the Notes is
eligible counterparties (as defined in the United Kingdom
Financial Conduct Authority (the "FCA") Handbook Conduct
of Business Sourcebook ("COBS")), professional clients (as
defined in UK MiFIR) and retail clients (as defined in point (8)
of Article 2 of Regulation (EU) No 2017/565 as it forms part of
domestic law by virtue of the European Union (Withdrawal) Act
2018); and (ii) all channels for distribution of the Notes are
appropriate. Any person subsequently offering, selling or
recommending the Notes (a "distributor") should take into
consideration the manufacturers' target market assessment;
however, each distributor subject to the FCA Handbook Product
Intervention and Product Governance Sourcebook (the "UK
MiFIR Product Governance Rules") is responsible for
undertaking its own target market assessment in respect of the
Notes (by either adopting or refining the manufacturers' target
market assessment) and determining appropriate distribution
channels.

-3-

4850-0617-1098 v.2



IBRD does not fall under the scope of application of UK
MiFIR. Consequently, IBRD does not qualify as an "investment
firm", "manufacturer" or "distributor" for the purposes of UK
MiFIR.
For the purposes of this provision, the term "manufacturers"
means Citigroup Global Markets Limited, J.P. Morgan
Securities plc and Merrill Lynch International.
OPERATIONAL INFORMATION
29. ISIN Code:
US459058JR58
30. CUSIP:
459058JR5
31. Common Code:
229818988
32. Any clearing system(s) other
Bookentry system of the Federal Reserve Banks; Euroclear
than Euroclear Bank SA/NV,
Bank SA/NV; Clearstream Banking S.A.
Clearstream Banking S.A. and
The Depository Trust
Company and the relevant
identification number(s):
33. Delivery:
Delivery against payment
34. Intended to be held in a
Not Applicable
manner which would allow

Eurosystem eligibility:

GENERAL INFORMATION
IBRD's most recent Information Statement was issued on September 23, 2020.
USE OF PROCEEDS
Supporting sustainable development in IBRD's member countries

The net proceeds from the sale of the Notes will be used by IBRD to finance sustainable
development projects and programs in IBRD's member countries (without being committed or
earmarked for lending to, or financing of, any particular projects, programs or activities). Prior to use,
the net proceeds will be invested by IBRD's Treasury in accordance with IBRD's liquid asset
management investment policies. IBRD's financing is made available solely to middle-income and
creditworthy lower-income member countries who are working in partnership with IBRD to eliminate
extreme poverty and boost shared prosperity, so that they can achieve equitable and sustainable
economic growth in their national economies and find sustainable solutions to pressing regional and
global economic and environmental problems. Projects and programs supported by IBRD are designed
to achieve a positive social impact and undergo a rigorous review and internal approval process aimed
at safeguarding equitable and sustainable economic growth.
IBRD integrates the following five global themes into its lending activities helping its borrowing
members create sustainable development solutions: climate change; gender; infrastructure, public-
private partnerships and guarantees; knowledge management; and fragility, conflict and violence.
IBRD's administrative and operating expenses are covered entirely by IBRD's various sources of
revenue (net income) consisting primarily of net loan revenues and investment income (as more fully
described in the Information Statement).

-4-

4850-0617-1098 v.2



SUPPLEMENTAL PROSPECTUS INFORMATION
The Dealers are represented by Sullivan & Cromwell LLP. From time to time Sullivan & Cromwell
LLP performs legal services for IBRD.
SUPPLEMENTAL U.S. FEDERAL INCOME TAX CONSIDERATIONS
You should carefully consider the matters set forth under "Tax Matters" in the accompanying
Prospectus. The following discussion supplements the section "Tax Matters" in the accompanying Prospectus
and is subject to the limitations and exceptions set forth therein.
You should consult with your own tax advisor concerning the consequences of investing in and
holding the Notes in your particular circumstances, including the application of state, local or other tax
laws and the possible effects of changes in federal or other tax laws.
Upon a sale or retirement of the Notes, a U.S. Holder will generally recognize capital gain or loss
equal to the difference, if any, between (i) the amount realized on the sale or retirement (other than amounts
attributable to accrued but unpaid interest, which would be treated as such) and (ii) the U.S. Holder's adjusted
tax basis in the Notes. A U.S. Holder's adjusted tax basis in the Notes generally will equal the cost of the
Notes to the U.S. Holder. Capital gain of individual taxpayers from the sale or retirement of the Notes held for
more than one year may be eligible for reduced rates of taxation. The deductibility of a capital loss is subject
to significant limitations.
Information with Respect to Foreign Financial Assets. Owners of "specified foreign financial assets"
with an aggregate value in excess of US$50,000 (and in some circumstances, a higher threshold) may be
required to file an information report with respect to such assets with their tax returns. "Specified foreign
financial assets" may include financial accounts maintained by foreign financial institutions (which may
include the Notes), as well as the following, but only if they are held for investment and not held in accounts
maintained by financial institutions: (i) stocks and securities issued by non-U.S. persons, (ii) financial
instruments and contracts that have non-U.S. issuers or counterparties, and (iii) interests in foreign entities.
Holders should consult their tax advisors regarding the application of this reporting obligation to their
ownership of the Notes.
Medicare Tax. A U.S. Holder that is an individual or estate, or a trust that does not fall into a special
class of trusts that is exempt from such tax, is subject to a 3.8% tax (the "Medicare tax") on the lesser of (1)
the U.S. Holder's "net investment income" (or "undistributed net investment income" in the case of an estate
or trust) for the relevant taxable year and (2) the excess of the U.S. Holder's modified adjusted gross income
for the taxable year over a certain threshold (which in the case of individuals is between US$125,000 and
US$250,000, depending on the individual's circumstances). A U.S. Holder's net investment income will
generally include its gross interest income and its net gains from the disposition of Notes, unless such interest
income or net gains are derived in the ordinary course of the conduct of a trade or business (other than a trade
or business that consists of certain passive or trading activities). If you are a U.S. Holder that is an individual,
estate or trust, you are urged to consult your tax advisors regarding the applicability of the Medicare tax to
your income and gains in respect of your investment in the Notes.
LISTING APPLICATION
These Final Terms comprise the final terms required for the admission to the Official List of the
Luxembourg Stock Exchange and to trading on the Luxembourg Stock Exchange's regulated market of the
Notes described herein issued pursuant to the Global Debt Issuance Facility of International Bank for
Reconstruction and Development.

-5-

4850-0617-1098 v.2



RESPONSIBILITY
IBRD accepts responsibility for the information contained in these Final Terms.
Signed on behalf of IBRD:

By:

Name:
Title:

Duly authorized




-6-

4850-0617-1098 v.2